B-Cell Targeted Therapies in Systemic Lupus Erythematosus

D D Gladman, D Hallett, A Kagal, M B Urowitz, Accurately describing changes in disease activity in Systemic Lupus Erythematosus. The Journal of Rheumatology. ,vol. 27, pp. 377- 379 ,(2000)

Caroline Gordon, Mary Gayed, Novel treatments for systemic lupus erythematosus. Current opinion in investigational drugs. ,vol. 11, pp. 1256- ,(2010)

Jun Zhang, Viktor Roschke, Kevin P. Baker, Zheng Wang, Graciela S. Alarcón, Barri J. Fessler, Holly Bastian, Robert P. Kimberly, Tong Zhou, Cutting Edge: A Role for B Lymphocyte Stimulator in Systemic Lupus Erythematosus Journal of Immunology. ,vol. 166, pp. 6- 10 ,(2001) , 10.4049/JIMMUNOL.166.1.6

Bevra H. Hahn, Maureen A. McMahon, Alan Wilkinson, W. Dean Wallace, David I. Daikh, John D. FitzGerald, George A. Karpouzas, Joan T. Merrill, Daniel J. Wallace, Jinoos Yazdany, Rosalind Ramsey-Goldman, Karandeep Singh, Mazdak Khalighi, Soo-In Choi, Maneesh Gogia, Suzanne Kafaja, Mohammad Kamgar, Christine Lau, William J. Martin, Sefali Parikh, Justin Peng, Anjay Rastogi, Weiling Chen, Jennifer M. Grossman, American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis Arthritis Care and Research. ,vol. 64, pp. 797- 808 ,(2012) , 10.1002/ACR.21664

Eamonn S. Molloy, Leonard H. Calabrese, Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: Evolving role of biologic therapies Arthritis & Rheumatism. ,vol. 64, pp. 3043- 3051 ,(2012) , 10.1002/ART.34468

Maria Dall'Era, Eliza Chakravarty, Daniel Wallace, Mark Genovese, Michael Weisman, Arthur Kavanaugh, Kenneth Kalunian, Patricia Dhar, Emmanuelle Vincent, Claudia Pena-Rossi, David Wofsy, , Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial. Arthritis & Rheumatism. ,vol. 56, pp. 4142- 4150 ,(2007) , 10.1002/ART.23047

Brad H Rovin, Richard Furie, Kevin Latinis, R John Looney, Fernando C Fervenza, Jorge Sanchez‐Guerrero, Romeo Maciuca, David Zhang, Jay P Garg, Paul Brunetta, Gerald Appel, LUNAR Investigator Group, None, Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study† Arthritis & Rheumatism. ,vol. 64, pp. 1215- 1226 ,(2012) , 10.1002/ART.34359

Maame B. Amissah-Arthur, Caroline Gordon, Contemporary treatment of systemic lupus erythematosus: an update for clinicians Therapeutic Advances in Chronic Disease. ,vol. 1, pp. 163- 175 ,(2010) , 10.1177/2040622310380100

J. T. Merrill, R. Burgos-Vargas, R. Westhovens, A. Chalmers, D. D'Cruz, D. J. Wallace, S. C. Bae, L. Sigal, J.-C. Becker, S. Kelly, K. Raghupathi, T. Li, Y. Peng, M. Kinaszczuk, P. Nash, The efficacy and safety of abatacept in patients with non–life‐threatening manifestations of systemic lupus erythematosus: Results of a twelve‐month, multicenter, exploratory, phase IIb, randomized, double‐blind, placebo‐controlled trial Arthritis & Rheumatism. ,vol. 62, pp. 3077- 3087 ,(2010) , 10.1002/ART.27601

J Cortés-Herández, J Ordi-Ros, M Labrador, A Segarra, J L Tovar, E Balada, M Vilardell-Tarres, Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone Lupus. ,vol. 12, pp. 287- 296 ,(2003) , 10.1191/0961203303LU340OA